Abstract
Purpose
To construct an EGF receptor (EGF-R)-mediated histone H10-based gene delivery system for gene therapy.
Methods
A recombinant DNA containing histone H10, EGF-R ligand, and endosomalytic domains was constructed in a prokaryotic vector and expressed in E. coli. Expression of the β-galactosidase (β-gal) gene in the tumor cells and tissues was observed after transduction of the β-gal gene packaged by purified fusion proteins in vitro and in vivo.
Results
As an extension of the research on previously reported chemically synthetic composite polypeptide gene delivery systems, this genetically engineered polypeptide has proved to be capable of targeting the β-galactosidase (β-gal) gene into EGF-R-positive cancer cells both in vitro and in vivo. We also studied the time course of β-gal gene expression in tumor tissues delivered in vivo by this polypeptide vector. At 24 h after administration, expression of the β-galactosidase gene in tumor reached peak levels. The dosage optimization of administered polyplex was also investigated. The optimal dose of polyplex per mouse was 1 μg DNA packaged by 3 μg of composite polypeptide.
Conclusions
The genetically engineered polypeptide based on histone H10 is a promising gene delivery system targeting EGF-R.
Similar content being viewed by others
References
Balicki D, Reisfeld RA, Pertl U, Beutler E, Lode HN (2000) Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proc Natl Acad Sci USA 97:11500–11504
Balicki D, Putnam CD, Scaria PV, Beutler E (2002) Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc Natl Acad Sci USA 99:7467–7471
Bonner WM (1975) Protein migration into nuclei. II. Frog oocyte nuclei accumulate a class of microinjected oocyte nuclear proteins and exclude a class of microinjected oocyte cytoplasmic proteins. J Cell Biol 64:431–437
Chen J, Stickles RJ, Daichendt KA (1994) Galactosylated histone-mediated gene transfer and expression. Hum Gene Ther 5:429–435
Cosset FL, Russell SJ (1996) Targeting retrovirus entry. Gene Ther 3:946–956
Cotten M, Wagner E (1993) Non-viral approaches to gene therapy. Curr Opin Biotechnol 4:705–710
Cristiano RJ, Roth JA (1996) Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 3: 4–10
Demirhan I, Hasselmayer O, Chandra A, Ehemann M, Chandra P (1998) Histone-mediated transfer and expression of the HIV-1 tat gene in Jurkat cells. J Hum Virol 1:430–440
Deol P, Khuller GK (1997) Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta 1334:161–172
Dingwall C, Allan J (1984) Accumulation of the isolated carboxyterminal domain of histone H1 in the Xenopus oocyte nucleus. EMBO J 3:1933–1937
Doenecke D, Tonjes R (1986) Differential distribution of lysine and arginine residues in the closely related histones H1 and H5. Analysis of a human H1 gene. J Mol Biol 187: 461–464
Du H, Chandaroy P, Hui SW (1997) Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim Biophys Acta 1326:236–248
Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G (1997) Nomenclature for synthetic gene delivery systems. Hum Gene Ther 8:511–512
Fritz JD, Herweijer H, Zhang G, Wolff JA (1996) Gene transfer into mammalian cells using histone-condensed plasmid DNA. Hum Gene Ther 7: 1395–1404
Goren D, Horowitz AT, Zalipsky S, Woodle MC, Yarden Y, Gabizon A (1996) Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br J Cancer 74:1749–1756
Gottschalk S, Sparrow JT, Hauer J, Mims MP, Leland FE, Woo SL, Smith LC (1996) A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther 3:48–57
Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K (2002) Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther 9:407–414
Hong K, Zheng W, Baker A, Papahadjopoulos D (1997) Stabalization of cationic liposome-plasmid DNA complexes by polyamines and poly (ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 400:233–237
Junbo H, Li Q, Zaide W, Yunde H (1999) Receptor-mediated interleukin-2 gene transfer into human hepatoma cells. Int J Mol Med 3:601–608
Kichler A, Mechtler K, Behr JP, Wagner E (1997) Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug Chem 8:213–221
Ledley FD (1994) Non-viral gene therapy. Current Opin Biotech 5:626–636
Lee TK, Han JS, Fan ST, Liang ZD, Tian PK, Gu JR, Ng IO (2001) Gene delivery using a receptor-mediated gene transfer system targeted to hepatocellular carcinoma cells. Int J Cancer 93:393–400
Liu X, Tian P, Yu Y, Yao M, Cao X, Gu J (2002) Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection. Cancer Gene Ther 9: 100-108
Moreland RB, Langevin GL, Singer RH, Garcea RL, Hereford LM (1987) Amino acid sequences that determine the nuclear localization of yeast histone 2B. Mol Cell Biol 7:4048–4057
Murata M, Kagiwada S, Takahashi S, Ohnishi S (1991) Membrane fusion induced by mutual interaction of the two charge-reversed amphiphilic peptides at neutral pH. J Biol Chem 266:14353–14358
Neumann G, Castrucci MR, Kawaoka Y (1997) Nuclear import and export of influenza virus nucleoprotein. J Virol 71:9690–9700
Perales JC, Ferkol T, Molas M, Hanson RW (1994) An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur J Biochem 226:255–266
Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269:12918–12924
Schwartz B, Ivanov MA, Pitard B, Escriou V, Rangara R, Byk G, Wils P, Crouzet J, Scherman D (1999) Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther 6:282–292
Tian PK, Ren SJ, Ren CC, Teng QS, Qu SM, Yao M, Gu JR (1999) A novel receptor-targeted gene delivery system for cancer gene therapy. Sci China C Life Sci 42:216–224
Veronese FM (2001) Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22:405–417
Wagner E, Cotten M, Foisner R, Birnstiel ML (1991) Transferrin-polycation- DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc Natl Acad Sci USA 88:4255–4259
Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML (1992) Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene- transfer vehicle. Proc Natl Acad Sci USA 89:7934–7938
Wu GY, Wu CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262: 4429–4432
Wyman TB, Nicol F, Zelphati O, Scaria PV, Plank C, Szoka FC Jr (1997) Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36:3008–3017
Zalipsky S, Qazen M, Walker JA 2nd, Mullah N, Quinn YP, Huang SK (1999) New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem 10:703–707
Zauner W, Blaas D, Kuechler E, Wagner E (1995) Rhinovirus-mediated endosomal release of transfection complexes. J Virol 69:1085–1092
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant from the Biotechnology Key Project, National High Technology Program of China (Project No. Z20-01-01). Patent involved: CN/02136162.2, WO98/18951 (PCT/CN97/00106)
Rights and permissions
About this article
Cite this article
Dai, FH., Chen, Y., Ren, CC. et al. Construction of an EGF receptor-mediated histone H10-based gene delivery system. J Cancer Res Clin Oncol 129, 456–462 (2003). https://doi.org/10.1007/s00432-003-0452-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-003-0452-8